• Info
  • Insider Trading

Mark Chin - Insider Trading & Ownership

Location
20 Berkeley Square, Mayfair, London, United Kingdom
Summary
The estimated net worth of Mark Chin is at least $35.5M dollars as of June 13, 2025. Mark Chin is the Director of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $35.5M. Mark Chin is the Director of Iterum Therapeutics plc and owns shares of Iterum Therapeutics plc (ITRM) stock worth about $25.6K.
Signature
By: /s/ Rahul Khara, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Mark Chin files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Mark Chin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN, IMRA Enliven Therapeutics, Inc. Director $35.5M Jun 2, 2022
ITRM Iterum Therapeutics plc Director $25.6K Jun 15, 2023
HARP Harpoon Therapeutics, Inc. Director $0 Mar 8, 2024
IRON Disc Medicine, Inc. Director Jun 11, 2025
PYXS Pyxis Oncology, Inc. Former Director Apr 21, 2022

Insider Transactions Reported by Mark Chin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.